Archives

by in
Entry Author Date Location
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push 05/29/12 Seattle
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers 04/20/12 Boston
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News 04/06/12 Boston
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle 03/30/12 San Francisco
Roche Raises Illumina Takeover Bid to $51/Share 03/29/12 San Diego
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Five Reasons Illumina Should Fight Roche’s Insulting Low-Ball Bid 03/05/12 National
Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris 02/23/12 Seattle
Will New Business Models Enhance or Endanger Drug Discovery? 02/16/12 National
Option to Buy: The New Face of Biotech Funding? 02/13/12 National
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis 01/30/12 Boston
“Vulture” Capital? Far From It 01/24/12 San Francisco
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Flagship, Joule, Constellation, and More of The Week’s Boston Dealmakers 01/18/12 Boston
Genentech Pours $95M Into Constellation’s Drug Platform 01/17/12 Boston
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More 01/06/12 San Diego
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs 01/05/12 Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Page 3 of 13 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.